APA

Hermans B. C. M., Derks J. L., Thunnissen E., van Suylen R. J., den Bakker M. A., Groen H. J. M., Smit E. F., Damhuis R. A., van den Broek E. C., Stallinga C. M., Roemen G. M., Speel E. J. M. & Dingemans A. C. (20200305). Prevalence and prognostic value of PD-L1 expression in molecular subtypes of metastatic large cell neuroendocrine carcinoma (LCNEC). : Lung cancer (Amsterdam, Netherlands).

Chicago

Hermans B C M, Derks J L, Thunnissen E, van Suylen R J, den Bakker M A, Groen H J M, Smit E F, Damhuis R A, van den Broek E C, Stallinga C M, Roemen G M, Speel E J M and Dingemans A-M C. 20200305. Prevalence and prognostic value of PD-L1 expression in molecular subtypes of metastatic large cell neuroendocrine carcinoma (LCNEC). : Lung cancer (Amsterdam, Netherlands).

Harvard

Hermans B. C. M., Derks J. L., Thunnissen E., van Suylen R. J., den Bakker M. A., Groen H. J. M., Smit E. F., Damhuis R. A., van den Broek E. C., Stallinga C. M., Roemen G. M., Speel E. J. M. and Dingemans A. C. (20200305). Prevalence and prognostic value of PD-L1 expression in molecular subtypes of metastatic large cell neuroendocrine carcinoma (LCNEC). : Lung cancer (Amsterdam, Netherlands).

MLA

Hermans B C M, Derks J L, Thunnissen E, van Suylen R J, den Bakker M A, Groen H J M, Smit E F, Damhuis R A, van den Broek E C, Stallinga C M, Roemen G M, Speel E J M and Dingemans A-M C. Prevalence and prognostic value of PD-L1 expression in molecular subtypes of metastatic large cell neuroendocrine carcinoma (LCNEC). : Lung cancer (Amsterdam, Netherlands). 20200305.